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Background: Infectious diseases and social contacts in early life have been proposed to modulate brain tumour risk during late
childhood and adolescence.
Methods: CEFALO is an interview-based case–control study in Denmark, Norway, Sweden and Switzerland, including children
and adolescents aged 7–19 years with primary intracranial brain tumours diagnosed between 2004 and 2008 and matched
population controls.
Results: The study included 352 cases (participation rate: 83%) and 646 controls (71%). There was no association with various
measures of social contacts: daycare attendance, number of childhours at daycare, attending baby groups, birth order or living
with other children. Cases of glioma and embryonal tumours had more frequent sick days with infections in the first 6 years of life
compared with controls. In 7–19 year olds with 4þ monthly sick day, the respective odds ratios were 2.93 (95% confidence interval:
1.57–5.50) and 4.21 (95% confidence interval: 1.24–14.30).
Interpretation: There was little support for the hypothesis that social contacts influence childhood and adolescent brain tumour
risk. The association between reported sick days due to infections and risk of glioma and embryonal tumour may reflect
involvement of immune functions, recall bias or inverse causality and deserve further attention.
Brain tumours are the second most frequent type of childhood
cancer with a high mortality rate and a high frequency of long-
term morbidity and psychosocial sequlae (Reimers et al, 2003). The
annual incidence rates range from 20 to 40 cases per million
children, with the highest rates reported in the Nordic countries
(Peris-Bonet et al, 2006; Lannering et al, 2009; Schmidt et al, 2011).
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Better knowledge of the aetiology of childhood and adolescent
brain tumour (CABT) for primary prevention strategies is
therefore important.
A review of epidemiologic studies by Schu¨z and Kaatsch, 2002
suggests that infections could initiate or modify the risk of CABT
similar to the infection hypothesis that has been proposed for
childhood acute lymphoblastic leukaemia (Schu¨z et al, 1999;
Roman et al, 2007; Kamper-Jorgensen et al, 2008). Exposure to
infectious agents early in childhood could cause an abnormal
immune response when exposed to infectious diseases later in
childhood (Kinlen, 1995; Greaves, 2006).
Some studies have not found an association between infectious
agents and CABT (Birch et al, 1990; Little, 1999; McKinney et al,
1999). Most of these studies, however, had small sample sizes and
therefore low statistical power to detect an association and other
studies have found an association between risk of CABT and
various measures of infectious diseases (Linet et al, 1996;
Dickinson et al, 2002; Shaw et al, 2006) or indications of an
association with exposure to polyoma viruses (SV40, JCV and
BKV) (Bunin, 2000; Vilchez and Butel, 2003; Khalili et al, 2003).
Children’s exposure to infectious diseases in early childhood is
most commonly through contact with other children (Ma et al,
2009). Studies have shown that attending daycare increases a child’s
risk of getting infectious diseases (Thrane et al, 2001; Kamper-
Jorgensen et al, 2006; von Linstow et al, 2008), indicating that social
contacts could reflect the general exposure to infections. Studies
investigating the relationship between social contacts and CABT
have, however, only found little or no evidence of an association
(Shaw et al, 2006; Harding et al, 2009; Schmidt et al, 2010).
To evaluate the infection hypothesis for CABT further, we
investigated the patterns of infectious diseases and social contacts
in early life in relation to risk of developing a brain tumour during
late childhood and adolescence in the CEFALO study.
MATERIALS AND METHODS
The CEFALO study is a multinational case–control study conducted
in Denmark, Norway, Sweden and Switzerland, with the primary
aim to investigate the possible association between CABT risk and
mobile phone use and other relevant exposures (Aydin et al, 2011).
Case and control ascertainment. Eligible cases were children
diagnosed with a primary intracranial brain tumour (Aydin et al,
2011) aged 7–19 years at the date of diagnosis. The study period
was from 1 January 2004 until 1 August 2008, but varied slightly
across the four countries (Denmark: January 2004–April 2008;
Sweden: April 2004–August 2008; Switzerland: May 2004–2008;
Norway: September 2004–August 2008).
To attain complete case ascertainment, cases were identified
both at hospitals and in country-specific disease registries (the
Danish National Cancer Registry (Tulinius et al, 1992; Storm et al,
1997); Danish Childhood Cancer Registry, Danish Pathology
Registry, Danish National Patient Registry, the Swedish Regional
Cancer Registries (Barlow et al, 2009), the Cancer Registry of
Norway (Larsen et al, 2009) and Swiss Childhood Cancer Registry).
Date of diagnosis was defined as date of first diagnostic imaging
confirming a CABT.
Two controls per case were randomly selected from nationwide
population registries in Scandinavia and in Switzerland from
communal registries, and were individually matched by age
(Denmark, Switzerland and Sweden: month of birth; Norway: year
of birth), gender and region. Exposure of controls was censored at
the date of diagnosis of the matched case.
Subjects diagnosed with Recklinghausen neurofibromatosis
(12 cases) and tuberous sclerosis (one case) were excluded as their
aetiology is genetic. Cases and controls with severe autism, severe
mental retardation or complete deafness before the date of
diagnosis were also excluded (two cases and two controls). In
addition, families with insufficient language skills to complete an
interview were excluded (15 cases and 36 controls). The study was
approved by the National Data Protection Boards and ethical
committees in all participating countries.
Data collection. Cases diagnosed before June 2006 (Norway:
December 2007) and corresponding controls were included
retrospectively. All other cases were included prospectively. A
structured personal interview was performed with the child and
one or preferably both parents by a trained interviewer during the
time period 2006–2009. For ethical reasons, the interview was
conducted at least 6 months after the date of diagnosis.
Questionnaire translations were validated and pilot tested in all
participating countries.
Variables and analysis strategy. We used the following variables
as measures of social contacts and of exposure to infectious disease:
living with other children before 6 years of age of index child (yes/
no); birth order (1st born/41st born); attending daycare in first
year of life (yes/no) and before 6 years of age(yes/no); attending
baby groups (at least once a week) within the first year of life (yes/
no); mean number of days where child’s general condition was
appreciably affected by infectious disease (once or less per month,
2–3 days per month, 4 days or more per month) at different ages
(o1, 1–o3, 3–o6 years), calculated as a weighted average of
answers provided per semester for the first 3 years of life and for
the next 3 years of life combined (see Supplementary Appendix 1
online). The list of infectious diseases included: cold, fever without
known cause, middle ear infection, tonsillitis, bronchitis, pneumo-
nia, skin infection, urinary tract infection, stomach flu and others
(e.g. whooping cough, 3-day fever, scarlet fever). For each child we
also assessed cumulative daycare exposure by calculating total
daycare childhours (categorised into quintiles) during the first 6
years of life as used by Ma et al (2002): Number of months
attending a specific daycare 4.35 (average number of weeks per
month) hours per week at daycare number of children at
daycare. The childhours were cumulated over all daycare facilities
attended during the time period of interest. As early brain tumour-
related symptoms might have influenced daycare attendance, all
daycare information for the past 2 years before diagnosis or end of
exposure date were disregarded (only relevant for the 7 and 8 year
olds in our study). In addition, information on allergic conditions
(yes/no) was available for all children, defined as having at any
time before diagnosis of the matched case: doctors diagnosis of
asthma, hay fever or eczema; or wheezing or whistling in the chest;
itchy/watery eyes and sneezing/runny/blocked nose not in
connection with a cold or the flu; or rash of folds of elbows,
knees, front of ankles, under buttock or around neck, eyes or ears.
For statistical analysis, tumours were classified as: ‘Glioma’
(astrocytomas, other gliomas), ‘intracranial embryonal CNS
tumours’ (including primitive neuroectodermal tumours (PNET))
and ‘Others’ (ependymoma, other specified intracranial neoplasms,
unspecified intracranial neoplasms).
Data were analysed by conditional logistic regression in SAS
(version 9.2; SAS Institute Inc., Cary, NC, USA). Relative risk
estimates were expressed as odds ratios (OR) with associated 95%
confidence intervals (CI). Highest attained education of parents as
a proxy for socioeconomic status was included in the models as
potential confounder, but did not alter the risk estimates and was
therefore omitted from the final model (data not shown).
RESULTS
In total, we invited 423 brain tumour cases and 909 controls and
their families to participate in the CEFALO study. We interviewed
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352 cases and 646 controls with participation rates of 83 and 71%,
respectively. The most common reasons for non-participation are
shown in Table 1.
The largest group of CABT in the study was glioma (55%)
followed by ‘other tumours’ (28%) and intracranial embryonal
tumours/PNET (18%) (Table 1). This corresponds to the overall
distribution of tumour types in the Nordic countries (Schmidt et al,
2011).
Overall there were slightly more boys than girls in the study.
Two-thirds of the participating children and adolescents were
between age 7 and 14 years, while only one third was between 15
and 19 years (Table 1). A large proportion of children attended
daycare before 6 years of age (87%). The majority of children
attended baby groups (72%) and most (94%) of the index children
were living together with siblings or other children. Regarding
monthly number of days with infectious disease during the first
6 years of life, the majority of children were reported to have
infectious disease once or less per month (67%), 20% 2–3 days per
month and 9% 4 days or more per month.
Overall, no OR of any measure of social contacts was statistically
significantly increased or decreased (Table 2); this did not change
when stratifying by gender (data not shown). Furthermore, no
changes in ORs were observed when controlling for allergy (never/
ever allergy) (data not shown). However, a tendency of slightly
increased risks were found for glioma and total childhours (only
significant for fourth quintile; OR: 3.39; 95% confidence interval
(CI): 1.54–7.46), living with other children before 6 years of age
(OR: 1.64; 95% CI: 0.73–3.67) and attending baby groups during
the first year of life (OR: 1.47; 95% CI: 0.95–2.28). Such a pattern
was not observed for other CABT.
With regard to infectious disease (Table 3), the OR for all CABT
types combined was 1.27 (95% CI: 0.89–1.80) for children having
2–3 sick days per month in the 0–6 years of age and 1.87
(95% CI: 1.19–2.97) for children with 4 or more sick days per month
(0–6 years) compared to children with one sick day or less per
month (Table 3). Girls tended to have higher risk estimates for
CABT than boys (data not shown). Controlling for diagnosed allergy
did not alter the risk estimates. When stratifying by tumour type,
increases were restricted to glioma and embryonal CNS tumours: an
average of 4 or more monthly sick days at ages 0, 0–2, 3–5 or 0–5
years was associated with significantly increased risk of glioma. The
observed risk was of similar magnitude, regardless of period of
exposure, with the highest risk seen when looking at sick days
over the first 6 years of life (OR: 2.93; 95% CI: 1.57–5.50). There was
a tendency for similar increases for embryonal CNS tumours, the
risk estimates tended to be slightly lower than for glioma, except
when looking at the first 6 years of life combined where the OR was
4.21 (95% CI: 1.24–14.30), numbers were, however, small and the CI
very wide.
For other CABTs, no indication of a risk increase with self-
reported number of sick days was observed (Table 3).
We tested for interaction between total daycare childhours and
number of days of infections (0–o6 years), as well as for birth
order and number of days of infections (0–o6 years), but no
interactions were found.
DISCUSSION
Overall, we found little evidence for an association between early-
life social contacts and CABT risk. There was no evidence of an
exposure–response effect of higher CABT risk for cumulative
childhours of attending daycare facilities. In all, confidence
intervals for all social contact measures were relatively wide and
no systematic patterns were observed. However, we found some
evidence for an association between number of sick days due to
infectious disease and CABT risk. When subdividing by tumour
type, the effect was restricted to glioma and embryonal CNS
tumours, with the results showing statistically significant positive
associations for sick days at all ages.
Our findings of no increased CABT risk in relation to
social contacts are broadly consistent with earlier studies, which
showed only small or no associations (Shaw et al, 2006; Harding
et al, 2009; Schmidt et al, 2010). The overall association of
CABT with sick days because of infections found in this study is in
agreement with some other studies; however, the majority of
studies did not find an association (Little, 1999) and, in addition,
no specific infectious agent had been identified (Schu¨z and
Kaatsch, 2002).
The observed association between CABT and infections could
result from a common underlying cause, for example, an
immunological factor that increases both risk of tumour
Table 1. Characteristics of cases and controls
Cases (%)
Controls
(%) Total (%)
No. of eligible cases and controls 423 909 1332
Reasons for not participating
Refusals 18 (25) 172 (65) 190 (57)
No contact could be established 5 (7) 70 (27) 75 (22)
No approval from treating
physician to contact case family
19 (27) — 19 (6)
Time shortage – study stopped
before consent was received
(mainly Norway)
14 (20) — 14 (4)
Other reasons 15 (21) 21 (8) 36 (11)
No. of participants 352 646 998
Gender
Boys 190 (54) 353 (55) 543 (54)
Girls 162 (46) 293 (45) 455 (46)
Age group (at reference date)
7–9 88 (25) 167 (26) 255 (26)
10–14 144 (41) 265 (41) 409 (41)
15–19 120 (34) 214 (33) 334 (33)
SES educational level of parents
Basic 20 (6) 26 (4) 46 (5)
Medium 188 (53) 336 (52) 524 (53)
High 144 (41) 279 (43) 423 (42)
Not living with parents — 2 (½) —
Missing — 3 (½) —
Type of tumour (ICCC groups)
Gliomas
Astrocytomas (IIIb) 162 (46) —
Other gliomas (IIId) 30 (9) —
Intracranial embryonal CNS
tumours/PNET (IIIc)
62 (18) —
Other —
Ependymoma (IIIa) 21 (6) —
Other specified intracranial
neoplasms (IIIe)
53 (15) —
Unspecified intracranial
neoplasms (IIIf)
24 (7) —
Abbreviations: CNS¼ central nervous system; PNET¼primitive neuroectodermal tumour;
ICCC¼ International Classification of Childhood Cancer; SES¼ socioeconomic status.
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development and susceptibility to infectious disease. Also, we
cannot rule out that inverse causality could be an explanation, as
having a yet undiagnosed brain tumour could make the case
children more susceptible to infections. Both of these explanations
would fit with the fact that we observed no clear association with
particular age periods when the infections occurred.
We estimated infections in the first 6 years of life from self-
report (infectious calendar developed for the purpose of this study,
see Supplementary Appendix 1 online). Accurate recall of
infectious episodes is, however, demanding (Schmidt et al, 2010)
and laypersons may have difficulty in separating sick days due to
infection from sick days for other reasons. Furthermore, case
parents may have over-reported exposure, in an attempt to provide
an explanation for the disease of their child; if so, one might expect
them to do this for all age periods in the questionnaire, but
inspection of the data for the most sick children showed no clear
evidence of such an effect (data not shown). Alternatively, one
could speculate that case parents might under-report sick days, as
infections may be trivial compared with the later burden of having
a child with a cancer diagnosis. In addition, common early
symptoms of CABT include headache, nausea and vomiting
(Wilne et al, 2007), and there may be a diagnostic delay of several
years (ng-Tan and Franco, 2007, 2008; Wilne et al, 2007; Raab and
Gartner, 2009) before the child is diagnosed with CABT; therefore,
it is possible some reported infections of cases could reflect
prodromal symptoms, even though we excluded any exposure
occurring within 2 years of diagnosis. Altogether, the above factors
may have introduced differential information bias. In this case we
would, however, expect to find the same effect for all subtypes of
CABT, whereas we only saw elevated risk estimates for glioma and
embryonal CNS tumours, suggesting that biased reporting of
infectious diseases is not a major concern. On the other hand, the
group of other CABTs is small and the difference may be due to
random variation.
Table 3. Self reported sick days from infectious disease and risk of CABT
Overall CABT Gliomas Embryonal CNS tumour Other CABT
Cases Controls OR 95% CI Cases Controls OR 95% CI Cases Controls OR 95% CI Cases Controls OR 95% CI
No. of days of infectious disease (0–o1 year)
Once or
less per
month
244 440 1.00 Reference 131 245 1.00 Reference 37 73 1.00 Reference 76 122 1.00 Reference
2–3 Days
per month
67 122 1.02 0.72–1.43 35 62 1.13 0.69–1.82 16 27 1.16 0.57–2.39 16 33 0.79 0.41–1.52
4 Days or
more per
month
32 39 1.60 0.96–2.65 23 21 2.37 1.22–4.63 5 6 1.75 0.52–5.88 4 12 0.53 0.16–1.74
No. of days of infectious disease (1–o3 years)
Once or
less per
month
214 418 1.00 Reference 111 235 1.00 Reference 35 68 1.00 Reference 68 115 1.00 Reference
2–3 Days
per month
81 131 1.23 0.88–1.72 45 68 1.41 0.88–2.26 15 33 0.91 0.43–1.95 21 30 1.24 0.67–2.28
4 Days or
more per
month
49 61 1.60 1.07–2.40 32 29 2.43 1.39–4.24 10 10 1.90 0.75–4.82 7 22 0.56 0.23–1.37
No. of days of infectious disease (3–o6 years)
Once or
less per
month
237 429 1.00 Reference 126 242 1.00 Reference 36 70 1.00 Reference 75 117 1.00 Reference
2–3 Days
per month
72 144 0.93 0.66–1.32 39 77 1.03 0.65–1.65 17 34 1.06 0.46–2.45 16 33 0.76 0.39–1.49
4 Days or
more per
month
37 43 1.62 1.00–2.63 25 18 2.87 1.45–5.67 7 7 2.08 0.64–6.70 5 18 0.43 0.15–1.25
No. of days of infectious disease (0–o6 years)
Once or
less per
month
227 436 1.00 Reference 118 245 1.00 Reference 34 77 1.00 Reference 75 114 1.00 Reference
2–3 Days
per month
71 117 1.27 0.89–1.80 40 59 1.60 0.97–2.62 15 23 1.48 0.68–3.22 16 35 0.75 0.38–1.49
4 Days or
more per
month
43 44 1.87 1.19–2.97 29 22 2.93 1.57–5.50 9 5 4.21 1.24–14.30 5 17 0.42 0.15–1.78
Abbreviations: CABT¼ childhood and adolescent brain tumour; CI¼ confidence intervals; CNS¼ central nervous system; OR¼odds ratio. Conditional logistic regression analyses, which
adjusts for matching factors (age, gender and region) expressed as OR values and with 95% CI.
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Another concern is if first born children may have had more sick
days due to more concerned first time parents or due to better
recollection of early life events (Sou et al, 2006). There was,
however, no evidence of differential reporting of sick days for the
first born children in our data as there was no statistically
significant interaction between birth order and number of sick days.
Regarding social contacts, the above-mentioned diagnostic delay
(Raaschou-Nielsen et al, 2006; ng-Tan and Franco, 2007, 2008;
Wilne et al, 2007; Raab and Gartner, 2009) suggests confounding
by indication as a potential concern as cases may have attended
daycare less often compared with controls because of prodromal
symptoms or other factors relating to a latent and undiagnosed
CABT. This would lead to an underestimation of the association
between social contacts and the risk of CABT.
Strengths of this study include the high participation rate,
reducing the potential of selection bias, and the use of nationwide
and high-quality registries (Tulinius et al, 1992; Storm et al, 1997;
Barlow et al, 2009) in addition to case validation from treating
physicians in hospitals ensuring a complete case ascertainment.
Furthermore, cases were validated by unequivocal diagnostic
imaging or histological confirmation ensuring correct diagnoses
of included cases. The complete Scandinavian and Swiss popula-
tion registers provided an optimal sampling frame for population-
based controls.
Daycare attendance before the age of 6 years was high in all
countries (range: 63–97%), making it a substantial source of social
contacts with other children and therefore also for repeated contact
with infectious agents. This in combination with a range of other
measures of social contacts and infectious diseases allowed us to
establish a quite detailed picture of the children’s total exposure.
This included also social contacts at home, where we could account
for the complex modern family structure with cohabiting full, half-
and step-siblings, whereas previous studies have not had any such
information or at best had registered maternal birth order
(Emerson et al, 1991; Linet et al, 1996; Heuch et al, 1998;
Mogren et al, 2003; Von Behren and Reynolds, 2003; Altieri et al,
2006; Shaw et al, 2006; Schmidt et al, 2010).
With such a generally high proportion of children attending
daycare, it became difficult to investigate daycare as a risk factor;
however, we created the score of childhours at daycare as exposure
gradient and did not observe an association with CABT risk when
comparing children of the highest and lowest quintile of childhours
at daycare. The distribution of attending daycare was skewed
between the countries; we did, however, not have sufficient
statistical power to perform country-specific analyses, but
sensitivity analysis, removing one country at a time, did not
substantially alter the results (data not shown).
Whereas interview information about birth order and living
with other children is expected to be accurate, information on
daycare attendance may be difficult to recollect many years later.
We believe, in contrast to the reported infectious diseases, that it is
unlikely that case and control parents remember daycare
attendance differently. There is, however, the possibility that
non-differential bias could influence the risk estimates, possibly
leading to a dilution of the risk.
In conclusion, this study provides little evidence of an
association between increased social contacts in early life, as
measured by daycare attendance, participation in baby groups or
living together with other children, and the risk of CABT in 7–19
year olds. However, we observed more frequent reported sick days
because of infections in the first 6 years of life associated with the
risk of glioma and possibly embryonal brain tumour. Although the
association could result from chance or recall bias, it needs
to be further studied to identify whether infectious disease
early in life could represent early symptoms of CABT, have
the same underlying cause as CABT or modulate the risk of
developing a CABT.
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